SEC Form 4 · accession 0001225208-19-004207
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Loretta V Cangialosi
Officer — Sr. Vice President, Controller
Period of report
Feb 27, 2019
Accepted (ET)
Mar 1, 2019 · 7:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2019 | M | 25,729 | $32.23 | A | 121,743 | D | |
| Common StockF2 | Feb 27, 2019 | A | 8,017 | $0.00 | A | 129,760 | D | |
| Common StockF3 | Feb 27, 2019 | F | 3,926 | $42.93 | D | 125,834 | D | |
| Common StockF4 | Feb 27, 2019 | F | 4,819 | $42.93 | D | 121,015 | D | |
| Common StockF5,F6 | Feb 27, 2019 | F | 15,890 | $42.31 | D | 105,125 | D | |
| Common StockF7 | Feb 28, 2019 | A | 3,482 | $0.00 | A | 108,607 | D | |
| Common Stock | holding | — | — | — | 2,110 | I | By Rule 16b-3 Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights | $32.23 | Feb 27, 2019 | M | 25,729 | D | Feb 27, 2019 | Feb 27, 2019 | Common Stock | 25,729 | 0 | D |
| Stock Appreciation RightsF8 | $43.35 | Feb 28, 2019 | A | 18,050 | A | Feb 28, 2024 | Feb 28, 2024 | Common Stock | 18,050 | 18,050 | D |
| Stock Appreciation RightsF9 | $43.35 | Feb 28, 2019 | A | 15,211 | A | Feb 28, 2026 | Feb 28, 2026 | Common Stock | 15,211 | 15,211 | D |
Explanation of responses
- F1The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- F2The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
- F3The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
- F4The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- F5The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- F6Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
- F7The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
- F8The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
- F9The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.